Allakos Company
Allakos is a biotechnology company that develops antibody-based therapeutics to treat various allergies and diseases.
Investor Type:
IPO
Investors Number:
11
Employee Number:
101-250
Last Funding Date:
2017
Headquarters:
San Carlos, California, United States
Last Funding Type:
Series B
Total Funding:
162449545
Founded Date:
2012
Industry:
Biopharma, Biotechnology, Health Care, Therapeutics
Estimated Revenue:
$1M to $10M